Sibasish Mohanty

Regional Centre for Biotechnology — India

Medicine · Health Sciences

5h-index181citations16works0.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Peptidase Inhibition and Analysis(4), Cancer Cells and Metastasis(3), Cancer-related Molecular Pathways(3), Wnt/β-catenin signaling in development and cancer(3), RNA modifications and cancer(3)

Publications16 total

Single-cell analysis identifies BASP1 as a driver of drug resistance and cell plasticity in oral squamous cell carcinoma
Journal of Biological Chemistry·2026Open Access
Arginine methylation on MSI2 drives resistance to PRMT1/5 inhibitors in lymphoma, controls translation and dictates cell fate
Blood·2025Open Access
NEK9-mediated Wnt signalling repressor TLE3 rewires Docetaxel resistance in cancer cells by inducing pyroptosis
British Journal of Cancer·2025· 1 cited
NEK9 ablation rewires docetaxel resistance through induction of ERK-mediated cancer cell pyroptosis
2024
CRISPR-based kinome-screening revealed MINK1 as a druggable player to rewire 5FU-resistance in OSCC through AKT/MDM2/p53 axis
Oncogene·2022· 15 citedOpen Access
<scp>CMTM6</scp> attenuates cisplatin‐induced cell death in <scp>OSCC</scp> by regulating <scp>AKT/c‐Myc</scp> ‐driven ribosome biogenesis
The FASEB Journal·2022· 14 cited
CMTM6 mediates cisplatin resistance in OSCC by regulating AKT/c-MYC driven ribosome biogenesis
2022Open Access
CRISPR-based kinome-screening revealed MINK1 as a druggable player to rewire 5FU-resistance in OSCC through AKT/MDM2/p53 axis
2021· 2 citedOpen Access
Correction: RRBP1 rewires cisplatin resistance in oral squamous cell carcinoma by regulating Hippo pathway
British Journal of Cancer·2021· 1 citedOpen Access
RRBP1 rewires cisplatin resistance in oral squamous cell carcinoma by regulating Hippo pathway
British Journal of Cancer·2021· 26 citedOpen Access
The Impact of m6A RNA Modification in Therapy Resistance of Cancer: Implication in Chemotherapy, Radiotherapy, and Immunotherapy
Frontiers in Oncology·2021· 64 citedOpen Access
CMTM6 drives cisplatin resistance by regulating Wnt signaling through ENO-1/AKT/GSK3β axis
JCI Insight·2021· 55 citedOpen Access
RRBP1 rewires cisplatin resistance in Oral Squamous Cell Carcinoma by regulating YAP-1
2020· 1 citedOpen Access
CMTM6 drives cisplatin resistance in OSCC by regulating AKT mediated Wnt signaling
2020Open Access
List of Contributors
Elsevier eBooks·2020
Three-dimensional tumor model and their implication in drug screening for tackling chemoresistance
Elsevier eBooks·2020· 2 cited

Frequent Co-authors

Rupesh Dash(15), Pallavi Mohapatra(14), Rachna Rath(11), Omprakash Shriwas(10), Saroj Majumdar(9), Shamima Azma Ansari(7), R Swain(7), Dillip Kumar Muduly(6), Sandeep Rai Kaushik(5), Rakesh Arya(5), Ranjan Kumar Nanda(5), Sunil K. Raghav(4), Manashi Priyadarshini(4), Arup Ghosh(3), Sugandh Kumar(3), Falak Pahwa(3), Krushna Chandra Murmu(2), Anshuman Dixit(2), Punit Prasad(2), Swatismita Priyadarsini(2)